Appraisal the significance of completion hysterectomy after definitive concurrent chemoradiotherapy for patients with locally advanced cervical adenocarcinoma: the ATTRACT study

作者
Xilin Yang,Jiawei Zhu,Yuncan Zhou,Yan You,Hui Guan,Zheng Miao,Peng Peng,Yonglan He,Qiu Guan,Zhiwei Yang,Yue Zhang,Junfang Yan,Ke Hu,Fu-Quan Zhang
出处
期刊:International Journal of Surgery [Wolters Kluwer]
标识
DOI:10.1097/js9.0000000000003549
摘要

Objective: To appraise if the completion hysterectomy after concurrent chemoradiotherapy (CCRT) would improve the survival outcomes for patients with locally advanced cervical adenocarcinoma (LACA). Methods: This study was conducted based on a large cohort including more than 200 LACA patients from Peking Union Medical College Hospital (PUMCH). The included patients were divided into CCRT alone and CCRT + surgery group, where overall survival (OS), progression free survival (PFS), loco-regional free survival (LRFS) and distant metastasis free survival (DMFS) were compared between two groups before and after propensity scoring matching (PSM). Cox regression analysis was performed in CCRT alone group to identify the risk factors impairing the survival probability. The survival outcomes were further compared between CCRT alone and CCRT + surgery group in different risk subgroups identified from cox regression analysis. Results: CCRT + surgery was observed to outperform CCRT alone in OS, PFS, LRFS and DMFS before PSM (All P <0.05), while the benefit of surgery couldn’t be maintained after PSM except for DMFS (3-yr DMFS: 76.8% vs 60.2%, P = 0.035). Uterus involvement (UI) was identified as the only risk factor for CCRT alone group. Surgery was found to increase the survival probability for patients with UI (All P <0.05), while it didn’t bring additional survival benefit for patients without UI (All P >0.05). In CCRT + surgery group, patients with pathological residual disease (RD) ≥ 1/2 myometrial infiltration (MI) had significant decreased survival compared to patients with RD<1/2MI or patients without RD (All P <0.05). Furthermore, post-operative chemotherapy didn’t improve survival outcomes in patients with RD<1/2MI, while it seemed to bring additional benefit for patients with RD≥1/2MI in terms of PFS with marginally significance ( P = 0.055). Conclusion: Completion hysterectomy after CCRT could increase DMFS for LACA patients, while not every LACA patients would retain OS benefit from surgery except for those with positive UI. Survival differences existed in different degree of RD among patients receiving post-radiation surgery and post-operative chemotherapy demonstrated a trend toward PFS benefit for patients with RD≥1/2MI.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
1秒前
孙嘉兴发布了新的文献求助30
1秒前
666完成签到,获得积分10
3秒前
王木木发布了新的文献求助10
4秒前
操作苦手小孟关注了科研通微信公众号
5秒前
yang发布了新的文献求助10
5秒前
5秒前
6秒前
6秒前
6秒前
7秒前
7秒前
大模型应助pengpengpeng采纳,获得10
9秒前
ZZZZ发布了新的文献求助10
10秒前
亮仔发布了新的文献求助10
10秒前
tpp发布了新的文献求助10
10秒前
11秒前
甜甜圈发布了新的文献求助10
11秒前
chaorenq完成签到,获得积分10
11秒前
一定毕业的我完成签到,获得积分20
12秒前
完美世界应助biubiu采纳,获得10
12秒前
swj发布了新的文献求助10
12秒前
14秒前
dde应助康利文采纳,获得10
14秒前
缘欲尘殇完成签到,获得积分10
14秒前
CinBatt发布了新的文献求助20
15秒前
mrwow完成签到 ,获得积分10
15秒前
酷波er应助小小章采纳,获得10
19秒前
19秒前
20秒前
李健应助前程似锦采纳,获得10
20秒前
上官若男应助小狮子采纳,获得10
20秒前
蘑菇蘑菇完成签到 ,获得积分10
20秒前
HH完成签到 ,获得积分10
22秒前
科研小贩发布了新的文献求助10
22秒前
搜集达人应助leegawei采纳,获得10
22秒前
wqb发布了新的文献求助20
22秒前
大个应助tpp采纳,获得10
26秒前
简单海露应助柔弱起眸采纳,获得10
26秒前
123完成签到,获得积分10
26秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
HYDROLYSE ACIDE DE QUELQUES DIOXASPIROCYCLANES 1314
Essentials of Carbohydrate Chemistry and Biochemistry, 4th Edition 800
Navigating Normative Orders. Interdisciplinary Perspectives 800
1 Peter and Christ's Descent to the Dead in Its Early Christian Reception 700
Organizational Behavior 510
Management and the Arts 510
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 工程类 有机化学 化学工程 生物化学 计算机科学 内科学 物理 复合材料 催化作用 细胞生物学 无机化学 光电子学 物理化学 电极 基因
热门帖子
关注 科研通微信公众号,转发送积分 7748321
求助须知:如何正确求助?哪些是违规求助? 9296436
关于积分的说明 20235000
捐赠科研通 7329569
什么是DOI,文献DOI怎么找? 3308782
关于科研通互助平台的介绍 2460546
邀请新用户注册赠送积分活动 2320861